Showing results (461-470 of 51,972) with videos related to
Sort By:
Pageof 5,198
Frontiers in Immunology|June 2, 2022
High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed LungsMiran Aswad, Haya Hamza, Antonina Pechkovsky, et al.Frontiers in Immunology|June 3, 2022
Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune MicroenvironmentSze Wing Wong, Joshua McCarroll, Kenneth Hsu, et al.Frontiers in Immunology|June 3, 2022
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron VariantNagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander J McAuley, et al.Frontiers in Immunology|June 3, 2022
Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia ModelsXiaobing Han, Roger Ortines, Ipsita Mukherjee, et al.Frontiers in Immunology|June 3, 2022
Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small MoleculeBashir Lawal, Alexander T H Wu, Hsu-Shan HuangFrontiers in Immunology|June 3, 2022
Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan MetabolismHao Cheng, Juan Liu, Dandan Zhang, et al.Frontiers in Immunology|June 6, 2022
Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic StrategyMahdi Eskandarian Boroujeni, Agata Sekrecka, Aleksandra Antonczyk, et al.Frontiers in Immunology|June 6, 2022
FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus FoliaceusMaud Maho-Vaillant, Magdalena Sips, Marie-Laure Golinski, et al.Frontiers in Immunology|June 6, 2022
Comparison of Immune Responses Elicited by SARS-CoV-2 mRNA and Recombinant Protein Vaccine CandidatesYixin Wu, Huicong Zhang, Liuxian Meng, et al.Frontiers in Immunology|June 6, 2022
Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCLNikeshan Jeyakumar, Melody SmithPageof 5,198